Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Rita Jain resigned as Director at Provention Bio, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Ashleigh Palmer; Avery Catlin; Rita Jain; John Jenkins; Wayne Pisano; and Nancy Wysenski) resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Tolpa was appointed as Director at Provention Bio, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Michael Tolpa, the sole director of Purchaser immediately prior to the Effective Time, became the sole director of the Company as the surviving corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eleanor L. Ramos was appointed as Chief Medical Officer at Provention Bio, Inc..
- Action
- appointed
- Role
- Chief Medical Officer
Exact text from the filing
(iv) Eleanor L. Ramos, Chief Medical Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Olivier Bogillot was appointed as President at Provention Bio, Inc..
- Action
- appointed
- Role
- President
Exact text from the filing
(i) Olivier Bogillot, President
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Francisco Leon was appointed as Chief Scientific Officer at Provention Bio, Inc..
- Action
- appointed
- Role
- Chief Scientific Officer
Exact text from the filing
(iii) Francisco Leon, Chief Scientific Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Stacy Apgar was appointed as Assistant Secretary at Provention Bio, Inc..
- Action
- appointed
- Role
- Assistant Secretary
Exact text from the filing
(ix) Stacy Apgar, Assistant Secretary
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Nancy Wysenski resigned as Director at Provention Bio, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Ashleigh Palmer; Avery Catlin; Rita Jain; John Jenkins; Wayne Pisano; and Nancy Wysenski) resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Jenkins resigned as Director at Provention Bio, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Ashleigh Palmer; Avery Catlin; Rita Jain; John Jenkins; Wayne Pisano; and Nancy Wysenski) resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Tolpa was appointed as President at Provention Bio, Inc..
- Action
- appointed
- Role
- President
Exact text from the filing
Michael Tolpa, the President and sole officer of Purchaser immediately prior to the Effective Time became the President and sole officer of the Company as the surviving corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Benedict Osorio was appointed as Chief Quality Officer at Provention Bio, Inc..
- Action
- appointed
- Role
- Chief Quality Officer
Exact text from the filing
(vi) Benedict Osorio, Chief Quality Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Wayne Pisano resigned as Director at Provention Bio, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Ashleigh Palmer; Avery Catlin; Rita Jain; John Jenkins; Wayne Pisano; and Nancy Wysenski) resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Debora Pellicano was appointed as Vice President, Chief Financial Officer at Provention Bio, Inc..
- Action
- appointed
- Role
- Vice President, Chief Financial Officer
Exact text from the filing
(ii) Debora Pellicano, Vice President, Chief Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jamie Haney was appointed as Secretary at Provention Bio, Inc..
- Action
- appointed
- Role
- Secretary
Exact text from the filing
(viii) Jamie Haney, Secretary
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jason Hoitt was appointed as Chief Commercial Officer at Provention Bio, Inc..
- Action
- appointed
- Role
- Chief Commercial Officer
Exact text from the filing
(v) Jason Hoitt, Chief Commercial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ashleigh Palmer resigned as Director at Provention Bio, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Ashleigh Palmer; Avery Catlin; Rita Jain; John Jenkins; Wayne Pisano; and Nancy Wysenski) resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Debora Pellicano was appointed as Director at Provention Bio, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Aventis, Inc., as the sole stockholder of the Company (“Aventis”), passed resolutions appointing Olivier Bogillot and Debora C. Pellicano as the sole directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christina Yi was appointed as Chief Operations Officer at Provention Bio, Inc..
- Action
- appointed
- Role
- Chief Operations Officer
Exact text from the filing
(vii) Christina Yi, Chief Operations Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Avery Catlin resigned as Director at Provention Bio, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Ashleigh Palmer; Avery Catlin; Rita Jain; John Jenkins; Wayne Pisano; and Nancy Wysenski) resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Tolpa was appointed as Treasurer at Provention Bio, Inc..
- Action
- appointed
- Role
- Treasurer
Exact text from the filing
(x) Michael Tolpa, Treasurer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Olivier Bogillot was appointed as Director at Provention Bio, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Aventis, Inc., as the sole stockholder of the Company (“Aventis”), passed resolutions appointing Olivier Bogillot and Debora C. Pellicano as the sole directors of the Company.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Provention Bio, Inc. underwent a change of control involving Sanofi S.A. for $25.00 per Share (closed 2023-04-27).
- Action
- change of control
- Counterparty
- Sanofi S.A.
- Consideration
- $25.00 per Share
- Closing
- 2023-04-27
Exact text from the filing
a tender offer (the “Offer”) to purchase all of the issued and outstanding shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company at a price of $25.00 per Share, to the seller in cash, without interest, but subject to any applicable withholding of taxes (the “Offer Price”) upon the terms and subject to the conditions set forth
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.